| Metric | FY2025 | FY2024 |
|---|---|---|
| License revenue | $13.0M+85.7% | $7.0M |
| Total revenue | $13.0M+85.7% | $7.0M |
| Research and development | $74.0M+15.3% | $64.2M |
| General and administrative | $20.0M+56.9% | $12.8M |
| Total operating expenses | $94.1M+22.1% | $77.0M |
| Loss from operations | -$81.1M-15.8% | -$70.0M |
| Change in fair value of convertible preferred stock forward | $8.9M | — |
| Interest income | $3.3M+2.5% | $3.2M |
| Other expense, net | -$50K-35.1% | -$37K |
| Total other income, net | $12.2M+280.7% | $3.2M |
| Net loss | -$68.9M-3.1% | -$66.8M |
| Deemed dividend | $1.5M | — |
| Net loss attributable to common stockholders | -$68.9M-0.8% | -$68.3M |
| Basic net loss per share of common stock | -$11220.00+75.2% | -$45290.00 |
| Diluted net loss per share of common stock | -$11220.00+75.2% | -$45290.00 |
| Weighted average basic shares of common stock outstanding | 6.14B+306.9% | 1.51B |
| Weighted average diluted shares of common stock outstanding | 6.14B+306.9% | 1.51B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.